2022 No. 168
The Novel Foods (Authorisations) and Smoke Flavourings (Modification of Authorisations) (Scotland) Regulations 2022
Made
Laid before the Scottish Parliament
Coming into force
for the purpose of regulation 1(2)
for the purpose of regulation 1(3)
The Scottish Ministers make these Regulations in exercise of the powers conferred by Articles 12(1)1 and 32A(3) of Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods, amending Regulation (EU) No. 1169/2011 of the European Parliament and of the Council and repealing Regulation (EC) No. 258/97 of the European Parliament and of the Council and Commission Regulation (EC) No. 1852/20012, Article 11(4) of Regulation (EC) No. 2065/2003 of the European Parliament and of the Council on smoke flavourings used or intended for use in or on foods3, and all other powers enabling them to do so.
There has been consultation as required by Article 9 of Regulation (EC) No. 178/2002 of the European Parliament and of the Council laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety4.
Citation, commencement and extent1
1
These Regulations may be cited as the Novel Foods (Authorisations) and Smoke Flavourings (Modification of Authorisations) (Scotland) Regulations 2022 and come into force in accordance with paragraphs (2) and (3).
2
Regulations 1, 2 and 4 come into force on 18 June 2022.
3
Regulation 3 comes into force on 30 June 2022.
4
These Regulations extend to Scotland only.
Interpretation2
1
In these Regulations—
“Regulation (EU) 1321/2013” means Commission Implementing Regulation (EU) No. 1321/2013 establishing the Union list of authorised smoke flavouring primary products for use as such in or on foods and/or for the production of derived smoke flavourings5, and
“Regulation (EU) 2017/2470” means Commission Implementing Regulation (EU) 2017/2470 establishing the Union list of novel foods in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods6.
2
Unless the contrary intention appears, any expression used both in these Regulations and in Regulation (EU) 1321/2013 or Regulation (EU) 2017/2470 has the same meaning as it bears in those Regulations.
Authorisation and change to conditions of use and specifications of novel foods3
The list of authorised novel foods set out in the Annex to Regulation (EU) 2017/2470 is amended in accordance with schedules 1 to 5.
Modification of authorisation holders: authorised smoke flavouring primary products4
1
The list of authorised smoke flavouring primary products set out in the Annex to Regulation (EU) 1321/2013 is amended in accordance with paragraphs (2) to (5).
2
In the entry for Scansmoke PB 1110 for—
a
“Azelis Denmark A/S” substitute “proFagus GmbH”, and
b
“Lundtoftegaardsvej 95, 2800, Lyngby, DENMARK” substitute “Uslarer Strasse 30, 37194 Bodenfelde, GERMANY”.
3
In the entry for Zesti Smoke Code 10 for—
a
“Mastertaste” substitute “Kerry Group Plc”, and
b
“Draycott Mills, Cam, Dursley, Gloucestershire, GL11 5NA, UNITED KINGDOM” substitute “Prince’s Street, Tralee, Co. Kerry, V92 EH11, IRELAND”.
4
In the entries for SmokeEz C-10 and SmokeEz Enviro-23 for—
a
“Red Arrow Products Company LLC” substitute “Kerry Group Plc”, and
b
“P.O. Box 1537, 633 South 20th street, Manitowoc, WI 54221-1537, USA” substitute “Prince’s Street, Tralee, Co. Kerry, V92 EH11, IRELAND”.
5
In the entry for Tradismoke™ A MAX for—
a
“Nactis” substitute “J. Rettenmaier & Söhne GmbH + CO KG”, and
b
“36, rue Gutenberg - ZI La Marinière, 91070 Bondoufle, FRANCE” substitute “Holzmühle 1, 73494 Rosenberg, GERMANY”.
SCHEDULE 1Change to conditions of use and specifications of 2’-Fucosyllactose/Difucosyllactose mixture (‘2’FL/DFL’) (microbial source)
1
In the entry for 2’-Fucosyllactose/Difucosyllactose mixture (‘2’-FL/DFL’) (microbial source) in Table 1 (authorised novel foods) insert at the end the following condition of use—
Specified food category
Maximum levels
Milk-based drinks and similar products intended for young children
1.2 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
2
For the entry for 2’-Fucosyllactose/Difucosyllactose mixture (‘2’-FL/DFL’) (microbial source) in Table 2 (specifications) substitute the following—
2’-Fucosyllactose /Difucosyllactose mixture (‘2’-FL/DFL’) (microbial source)
Description/Definition:
2’-Fucosyllactose/Difucosyllactose mixture is a purified, white to off-white powder or agglomerates thereof that is produced by a microbial process.
Source: Genetically modified strain of Escherichia coli strain K-12 DH1
Characteristics/Composition:
Appearance: White to off-white powder or agglomerates
Sum of 2’-Fucosyllactose, Difucosyllactose, D-Lactose, L-Fucose, and 3-Fucosyllactose (% of dry matter): ≥ 92.0 % (w/w)
Sum of 2’-fucosyllactose and difucosyllactose (% of dry matter): ≥ 85.0 % (w/w)
2’-Fucosyllactose (% of dry matter): ≥ 75.0 % (w/w)
Difucosyllactose (% of dry matter): ≥ 5.0 % (w/w)
D-Lactose: ≤ 10.0 % (w/w)
L-Fucose: ≤ 1.0 % (w/w)
2’-Fucosyl-D-lactulose: ≤ 2.0 % (w/w)
Sum of other carbohydrates7: ≤ 6.0 % (w/w)
Moisture: ≤ 6.0 % (w/w)
Ash, sulfated: ≤ 0.8 % (w/w)
pH (20 °C, 5 % solution): 4.0-6.0
Residual protein: ≤ 0.01 % (w/w)
Microbiological criteria:
Aerobic mesophilic bacteria total plate count: ≤ 1000 CFU/g
Enterobacteriaceae: ≤ 10 CFU/g
Salmonella sp.: Negative/25 g
Yeast: ≤ 100 CFU/g
Mould: ≤ 100 CFU/g
Residual endotoxins: ≤ 10 EU/mg
CFU: Colony Forming Units; EU: Endotoxin Units
SCHEDULE 2Authorisation of Schizochytrium sp. (FCC-3204) oil
1
In Table 1 (authorised novel foods), after the entry for Schizochytrium sp. (ATCC PTA-9695) oil insert the following entry—
Schizochytrium sp.(FCC-3204) oil
Specified food category
Maximum levels of DHA
Food supplements as defined in the Food Supplements (Scotland) Regulations 20038 excluding food supplements for infants and children under 3 years of age
1 g/day
The designation of the novel food on the labelling of the foodstuffs containing it is “Oil from the microalgae Schizochytrium sp.”.
Infant formula and follow-on formula as defined in Regulation (EU) 609/20139
In accordance with Regulation (EU) 609/2013
The labelling of food supplements containing Schizochytrium sp. (FCC-3204) oil must bear a statement that they should not be consumed by infants and children under 3 years of age.
2
In Table 2 (specifications), after the entry for Schizochytrium sp. (ATCC PTA-9695) oil insert the following entry–
Schizochytrium sp.(FCC-3204) oil
Description/Definition:
The novel food is an oil produced from the strain FCC-3204 of the microalgae Schizochytrium sp.
Composition:
Acid value: ≤ 0.5 mg KOH (potassium hydroxide)/g
Peroxide value (PV): ≤ 5.0 meq (milliequivalent)/kg oil
Moisture and volatiles: ≤ 0.05 %
Unsaponifiables: ≤ 4.5 %
Trans-fatty acids: ≤ 1.0 %
Docosahexaenoic acid (DHA): ≥ 32.0 %
p-anisidine value: ≤ 10
SCHEDULE 3Authorisation of Schizochytrium sp. (WZU477) oil
1
In Table 1 (authorised novel foods), after the entry for Schizochytrium sp. (T18) oil insert the following entry—
Schizochytrium sp. (WZU477) oil
Specified food category
Maximum levels of DHA
The designation of the novel food on the labelling of the foodstuffs containing it is “Oil from the microalgae Schizochytrium sp.”.
Included in the list on 30 June 2022.
Infant formula and follow-on formula as defined in Regulation (EU) 609/2013
In accordance with Regulation (EU) 609/2013
This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.
Applicant: Progress Biotech BV of Canaalstaete, Kanaalweg 33, 2903LR Capelle aan den Ijssel, the Netherlands.
During the period of data protection, the novel food Schizochytrium sp. (WZU477) oil is authorised for placing on the market within Scotland only by Progress Biotech BV unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Progress Biotech BV.
The data protection will expire at the end of 29 June 2027.
2
In Table 2 (specifications), after the entry for Schizochytrium sp. (T18) oil insert the following entry—
Schizochytrium sp. (WZU477) oil
Description/Definition:
The novel food is an oil produced from the strain WZU477 of the microalgae Schizochytrium sp.
Composition:
Acid value: ≤ 0.5 mg KOH (potassium hydroxide)/g
Peroxide value (PV): ≤ 5.0 meq (milliequivalent)/kg oil
Moisture and volatiles: ≤ 0.05 %
Unsaponifiables: ≤ 4.5 %
Trans-fatty acids: ≤ 1.0 %
Docosahexaenoic acid (DHA): ≥ 32.0 %
p-anisidine value: ≤ 10
SCHEDULE 4Authorisation of 3’Sialyllactose (3’-SL) sodium salt (microbial source)
1
In Table 1 (authorised novel foods), after the entry for Selenium-containing yeast (Yarrowia lipolytica) biomass insert the following entry—
3’-Sialyllactose (3’-SL) sodium salt (microbial source)
Specified food category
Maximum levels (expressed as 3’- Sialyllactose)
The designation of the novel food on the labelling of the foodstuffs containing it is “3’-Sialyllactose sodium salt”.
Included in the list on 30 June 2022.
Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products
0.25 g/L
This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.
Flavoured fermented milk-based products including heat-treated products
0.25 g/L (beverages)
The labelling of food supplements containing 3’-Sialyllactose sodium salt must bear a statement that they should not be consumed:
a) if foods containing added 3’-Sialyllactose sodium salt are consumed the same day,
b) by infants and young children.
2.5 g/kg (products other than beverages)
Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark.
Unflavoured fermented milk-based products
0.25 g/L (beverages)
During the period of data protection, the novel food 3’-sialyllactose sodium salt is authorised for placing on the market within Scotland only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S.
0.5 g/kg (products other than beverages)
Beverages (flavoured drinks, excluding drinks with a pH less than 5)
0.25 g/L
Cereal bars
2.5 g/kg
Infant formula as defined in Regulation (EU) 609/2013
0.2 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
Follow-on formula as defined in Regulation (EU) 609/2013
0.15 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
The data protection will expire at the end of 29 June 2027.
Processed cereal-based food and baby food for infants and young children as defined in Regulation (EU) 609/2013
0.15 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
1.25 g/kg for products other than beverages
Milk-based drinks and similar products intended for young children
0.15 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
Total diet replacement foods for weight control as defined in Regulation (EU) 609/2013
0.5 g/L (beverages)
5 g/kg (products other than beverages)
Food for special medical purposes as defined in Regulation (EU) 609/2013
In accordance with the particular nutritional requirements of the persons for whom the products are intended
Food supplements as defined in the Food Supplements (Scotland) Regulations 2003, excluding food supplements for infants and young children
0.5 g/day.
2
In Table 2 (specifications), after the entry for Selenium-containing yeast (Yarrowia lipolytica) biomass insert the following entry—
3’‐Sialyllactose (3’‐SL) sodium salt (microbial source)
Description:
3’-Sialyllactose (3’-SL) sodium salt is a purified, white to off-white powder or agglomerate that is produced by a microbial process and contains limited levels of lactose, 3’-sialyl-lactulose, and sialic acid.
Source: Genetically modified strain of Escherichia coli K-12 DH1.
Definition:
Chemical formula: C23H38NO19Na
Chemical name: N-Acetyl-α-D-neuraminyl-(2→3)-β-D-galactopyranosyl-(1→4)-D-glucose, sodium salt
Molecular mass: 655.53 Da
CAS No 128596-80-5
Characteristics/Composition:
Appearance: White to off-white powder or agglomerate
Sum of 3’-Sialyllactose sodium salt, D-Lactose, and Sialic acid (% of dry matter): ≥ 90.0 % (w/w)
3’-Sialyllactose sodium salt (% of dry matter): ≥ 88.0 % (w/w)
D-Lactose: ≤ 5.0 % (w/w)
Sialic acid: ≤ 1.5 % (w/w)
3’-Sialyl-lactulose: ≤ 5.0 % (w/w)
Sum of other carbohydrates: ≤ 3.0 % (w/w)
Moisture: ≤ 8.0 % (w/w)
Sodium: 2.5 – 4.5 % (w/w)
Chloride: ≤ 1.0 % (w/w)
pH (20 °C, 5 % solution): 4.5 -6.0
Residual protein: ≤ 0.01 % (w/w).
Microbiological criteria:
Aerobic mesophilic bacteria total plate count: ≤ 1000 CFU/g
Enterobacteriaceae: ≤ 10 CFU/g
Salmonella sp.: Absence in 25 g
Yeast: ≤ 100 CFU/g
Mould: ≤ 100 CFU/g
Residual endotoxins: ≤ 10 EU/mg
CFU: Colony Forming Units; EU: Endotoxin Units
SCHEDULE 5Authorisation of 6′‐Sialyllactose (6′‐SL) sodium salt (microbial source)
1
In Table 1 (authorised novel foods), after the entry for 3’Sialyllactose (3’-SL) sodium salt (microbial source)10 insert the following entry—
6’-Sialyllactose (6’-SL) sodium salt (microbial source)
Specified food category
Maximum levels (expressed as 6’-Sialyllactose)
The designation of the novel food on the labelling of the foodstuffs containing it is “6’-Sialyllactose sodium salt”.
Included in the list on 30 June 2022.
Unflavoured pasteurised and unflavoured sterilised (including UHT) milk products
0.5 g/L
This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.
The labelling of food supplements containing 6’-Sialyllactose (6’-SL) sodium salt must bear a statement that they should not be consumed:
(a) if foods containing added 6’-Sialyllactose sodium salt are consumed on the same day,
(b) by infants and young children.
Unflavoured fermented milk-based products
0.5 g/L (beverages)
2.5 g/kg (products other than beverages)
Flavoured fermented milk-based products including heat-treated products
0.5 g/L (beverages)
Applicant: Glycom A/S, Kogle Allé 4, DK-2970 Hørsholm, Denmark.
5.0 g/kg (products other than beverages)
During the period of data protection, the novel food 6’-sialyllactose sodium salt is authorised for placing on the market within Scotland only by Glycom A/S, unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Glycom A/S.
Beverages (flavoured drinks, excluding drinks with a pH less than 5)
0.5 g/L
Cereal bars
5.0 g/kg
Infant formula as defined in Regulation (EU) 609/2013
0.4 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
Follow-on formula as defined in Regulation (EU) 609/2013
0.3 g/L in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
Processed cereal-based food and baby food for infants and young children as defined in Regulation (EU) 609/2013
0.3 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
The data protection will expire at the end of 29 June 2027.
2.5 g/kg for products other than beverages
Milk based drinks and similar products intended for young children
0.3 g/L (beverages) in the final product ready for use, marketed as such or reconstituted as instructed by the manufacturer
Total diet replacement foods for weight control as defined in Regulation (EU) 609/2013
1.0 g/L (beverages)
10.0 g/kg (products other than beverages)
Food for special medical purposes as defined in Regulation (EU) 609/2013
In accordance with the particular nutritional requirements of the persons for whom the products are intended
Food supplements as defined in the Food Supplements (Scotland) Regulations 2003, excluding food supplements for infants and young children
1.0 g/day.
2
In Table 2 (specifications), after the entry for 3’Sialyllactose (3’-SL) sodium salt (microbial source) insert the following entry—
6′‐Sialyllactose (6′‐SL) sodium salt (microbial source)
Description:
6’-Sialyllactose (6’-SL) sodium salt is a purified, white to off-white powder or agglomerate that is produced by a microbial process and contains limited levels of lactose, 6’-sialyl-lactulose, and sialic acid.
Source: Genetically modified strain of Escherichia coli K-12 DH1.
Definition:
Chemical formula: C23H38NO19Na
Chemical name: N-Acetyl-α-D-neuraminyl-(2→6)-β-D-galactopyranosyl-(1→4)-D-glucose, sodium salt
Molecular mass: 655.53 Da
CAS No 157574-76-0
Characteristics/Composition:
Appearance: White to off-white powder or agglomerate
Sum of 6’-Sialyllactose sodium salt, D-Lactose and Sialic acid (% of dry matter): ≥ 94.0 % (w/w)
6’-Sialyllactose sodium salt (% of dry matter): ≥ 90.0 % (w/w)
D-Lactose: ≤ 5.0 % (w/w)
Sialic acid: ≤ 2.0 % (w/w)
6’-Sialyl-lactulose: ≤ 3.0 % (w/w)
Sum of other carbohydrates: ≤ 3.0 % (w/w)
Moisture: ≤ 6.0 % (w/w)
Sodium: 2.5-4.5 % (w/w)
Chloride: ≤ 1.0 % (w/w)
pH (20 °C, 5 % solution): 4.5-6.0
Residual protein: ≤ 0.01 % (w/w)
Microbiological criteria:
Aerobic mesophilic bacteria total plate count: ≤ 1 000 CFU/g
Enterobacteriaceae: ≤ 10 CFU/g
Salmonella sp.: Absence in 25 g
Yeast: ≤ 100 CFU/g
Mould: ≤ 100 CFU/g
Residual endotoxins: ≤ 10 EU/mg
CFU: Colony Forming Units; EU: Endotoxin Units
(This note is not part of the Regulations)